DexCom DXCM recently announced that it will begin rolling out its fully reimagined Stelo app experience in the United States ...

DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...

California-based Dexcom (DXCM) is a global medical device company that makes glucose monitoring systems for people with diabetes. It recently introduced a new product named Dexcom ONE to expand access ...

DexCom posted another quarter of robust top-line growth that leaves the firm on track to meet our full-year expectations, and we’re standing behind our $315 fair value estimate. Importantly, DexCom’s ...

Dexcom shares plunged on disappointing revenue and weak guidance. The stock was down 13% for the year as of Thursday's close. Dexcom makes continuous glucose monitors for patients with diabetes. In ...

DexCom To Collaborate With The Life Sciences Team At Google On The Development Of Breakthrough Technologies To Change The Future Of Diabetes Management SAN DIEGO, Aug. 11, 2015 /PRNewswire/ -- DexCom, ...

On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 ...